Data as of Q4 2025 (Dec 31, 2025)

Medline Inc

(MDLN)

Financial Statements · SEC EDGAR XBRL

Revenue
$28.43B
+11.5%
Net Income
$1.2T
EPS
$-0.01
Gross Margin
26.4%
Op. Income
$2.21B
+3.1%
FCF
$1.30B
-8.3%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Total Operating Expenses
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
Shares Outstanding (Diluted)
FY 2025
FY 2024
FY 2023
$28.43B
$25.51B
$23.23B
$28.43B
$25.51B
$23.23B
$20.91B
$18.53B
$17.35B
$7.52B
$6.98B
$5.88B
$4.52B
$4.11B
$3.87B
$80.0M
$67.0M
$60.0M
$5.31B
$4.83B
$4.63B
$2.21B
$2.15B
$1.25B
-$964.0M
-$900.0M
-$986.0M
$1.25B
$1.25B
$264.0M
$91.0M
$46.0M
$30.0M
$1.2T
-
-
$-0.01
-
-
$-0.01
-
-
810.0M
-
-